Why is Piramal Pharma falling/rising?

As of 22-Jul, Piramal Pharma Ltd's stock price is currently at 205.35, reflecting a decrease of 6.35, or 3.0%. Today's performance indicates that the stock has underperformed its sector by 2.09%, with an intraday low of Rs 204.7, which represents a decline of 3.31%. Over the past week, the stock has seen a decline of 5.08%, while it has shown a positive return of 4.96% over the past month. Despite a strong annual return of 35.46%, the stock's year-to-date performance is notably poor at -22.74%. The company has demonstrated healthy long-term growth, with operating profit increasing significantly, yet it faces challenges such as a high Debt to EBITDA ratio of 3.21 times, which indicates a low ability to service debt.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has only declined by 0.47% over the past week. This underperformance may be attributed to the company's high institutional holdings of 46.27%, which suggests that these investors are closely monitoring the company's fundamentals. While the stock has generated substantial returns over the past year, its current struggles with profitability, as indicated by a low Return on Equity of 0.87%, and the recent price decline may be causing investor concern. Overall, the combination of strong historical performance and current financial challenges is contributing to the stock's recent downward movement.